Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cytopathological examination of effusions can be limited in sensitivity for detecting malignant epithelial cells.
• Accurate detection of cancer cells in effusions is crucial for diagnosis and treatment planning.

Purpose of the Study:

• To develop and validate a sensitive and specific molecular assay for detecting epithelial cancer cells in pleural and peritoneal effusions.
• To improve upon the diagnostic capabilities of routine cytopathological examination.

Main Methods:

• A two-stage assay combining immunomagnetic bead selection for cancer cell enrichment.
• Reverse transcriptase polymerase chain reaction (RT-PCR) for detecting epithelial glycoprotein 2 (EGP-2) RNA.
• Validation using cytologically negative effusion cells spiked with known cancer cells and analysis of 110 clinical effusion samples.

Main Results:

• The assay demonstrated high specificity, detecting ten added breast cancer cells among 10(7) negative cells.
• Of 18 cytologically positive/suspicious effusions, 17 (94%) were positive for EGP-2 RNA.
• 11 of 92 (12%) cytologically negative samples were EGP-2 RNA positive, including six patients with a history of carcinoma.

Conclusions:

• The developed molecular assay is highly specific and increases the sensitivity for detecting malignant epithelial cells in effusions.
• This method can serve as a valuable adjunct to conventional cytopathological examination for improved cancer diagnosis.